July 7, 2025: As the Indian stock market continues to show mixed trends in July 2025, investors are closely watching sector-specific performers. Two such stocks—Glenmark Pharmaceuticals from the healthcare sector and Asian Paints from the consumer goods and housing segment—have shown contrasting movements this month. While Glenmark is moving near its 52-week high, Asian Paints has slipped from its earlier peak and is currently consolidating.
Let’s take a closer look at how both stocks are performing and what investors should expect going forward.
Glenmark has been on a strong uptrend in the past year. After touching a low of ₹1,236 around October 2024, the stock has steadily moved upwards, currently trading close to ₹1,783.50, just shy of its 52-week high.
This rise isn’t just market hype—it’s backed by strong financial results. In FY 2024–25, Glenmark reported:
The pharma major is benefitting from an increased demand for generics and specialty medicines in both domestic and export markets. Its pipeline of new launches, especially in dermatology and respiratory therapies, has created renewed investor interest.
Market experts believe Glenmark still has more upside left, though some caution is advised due to its relatively high valuation (around 49x P/E). For long-term investors looking for healthcare exposure, Glenmark remains a strong candidate with solid growth potential.
Asian Paints is a household name and a long-time favourite among blue-chip investors. However, the stock has been under pressure since it peaked at ₹3,394 in September 2024. It has since corrected nearly 30% and is now hovering around ₹2,424.20.
Several factors are weighing on the stock:
Despite these headwinds, Asian Paints has continued to maintain its leadership in the decorative paints segment and has been expanding its reach in home décor and waterproofing.
The company is set to announce its Q1 FY25 results in a board meeting scheduled for July 29–30, which could bring clarity to its future direction. If results meet or beat expectations, the stock may find strong support and even bounce back.
Analyst recommendations are currently mixed. While CLSA has given an “Underperform” rating, others like ICICI Securities are moderately optimistic on the long-term prospects of the paints sector.
| Feature | Glenmark Pharma | Asian Paints |
|---|---|---|
| Latest Share Price | ₹1,783.50 | ₹2,424.20 |
| 52-Week Movement | Near high (₹1,830.95) | ~30% below high |
| Sector | Pharma | Consumer / Paints |
| 1-Year Return | +41.7% | +6.3% (YTD) |
| Key Triggers | Drug pipeline, earnings | Q1 results, CCI update |
| Analyst View | Bullish with caution | Mixed to Neutral |
If you’re a medium-to-long-term investor looking for growth in the healthcare sector, Glenmark offers a solid opportunity. Its strong financials, new product pipeline, and overall pharma market strength support a positive view. However, current valuations are slightly high, so one should accumulate on dips.
Though currently under pressure, Asian Paints is a fundamentally sound company. If you’re already holding it, it may be wise to wait until the Q1 results later this month before taking fresh positions. For new investors, it’s best to enter gradually or after further clarity.
As of July 7, 2025, both Glenmark and Asian Paints represent different stories—one of momentum and growth, and the other of a possible turnaround. Your choice should depend on your risk profile, investment horizon, and sectoral preference. Always consider current events and financial updates before making a move in the stock market.
Author rejects claims of communal bias in Bollywood after composer’s interview sparks debate January 17,…
World Bank chief joins proposed interim governance body as US plans temporary oversight of Gaza…
Government says film-making falls under relevant authorities, not External Affairs Ministry January 17, 2026: Ahead…
Ajay Devgn–Riteish Deshmukh starrer to hit theatres on June 12, 2026 January 17, 2026: The…
PM calls for BJP government, targets TMC ahead of Assembly polls January 17, 2026: Prime…
PM cites BMC win, targets TMC governance ahead of Bengal polls January 17, 2026: Prime…
